Can a simple support program keep HIV-positive moms healthy?
NCT ID NCT05841797
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether screening pregnant women with HIV for their risk of dropping out of care, then offering tailored support (counseling sessions in person or by phone), could help them stay in treatment and keep the virus under control. The study involved 120 women in Kisumu County, Kenya, and measured retention and viral suppression up to 6 months after birth. The goal is to find a practical way to improve health for mothers and babies in low-resource settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
behavioral intervention (Program Management Plus, delivered in-person or by phone)
What this could lead to
If successful, this approach could help pregnant women with HIV stay in care and keep the virus under control, reducing health risks for mothers and babies.
What could go wrong
This is a small pilot study (120 participants) in one region of Kenya, so results may not apply elsewhere. The intervention is behavioral, not a new drug, so it won't cure HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kenya Medical Research Institute
Nairobi, Kenya